Abstract
The last decade has witnessed an impressive upsurge in the utilization of microarray platforms for biomedical research. However, the application of this emerging technology in medical practice lagged behind. This lag is understandable because there are specific issues pertaining to the utilization of clinical samples, which has to be rigorously addressed and overcome before microarrays enter mainstream medical practice. Such issues include cost, ethics, the complexity and heterogeneity of human tissue architecture, and their corresponding diseases, the type of tissues to be used, nucleic acids amplification, and experimental variability. As microarrays enter, albeit cautiously, the frontline of clinical practice, investigators and clinicians require to set up protocols that address these issues. This chapter decribes the methods used for nucleic acids preparation from frozen and formalin-fixed paraffin-embedded human tissues using macro-and microdissection and show their suitability for use in microarray experiments.
Key Words
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467–470.
Golub, T. R., Slonim, D. K., Tamayo, P., et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531–537.
Alizadeh, A. A., Eisen, M. B., Davis, R. E., et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511.
van’t Veer, L. J., Dai, H., van de Vijver, M. S., et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536.
Snijders, A. M., Meijer, G. A., Brakenhoff, R. H., van den Brule, A. J., and van Diest, P. J. (2000) Microarray techniques in pathology: tool or toy? Mol. Pathol. 53, 289–294.
Forster, T., Roy, D., and Ghazal, P. (2003) Experiments using microarray technology: limitations and standard operating procedures. J. Endocrinol. 178, 195–204.
Russo, G., Zegar, C., and Giordano, A. (2003) Advantages and limitations of microarray technology in human cancer. Oncogene 22, 6497–6507.
Ein-Dor, L., Kela, I., Getz, G., Givol, D., and Domany, E. (2005) Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 21, 171–178.
Yuen, T., Wurmbach, E., Pfeffer, R. L., Ebersole, B. J., and Sealfon, S. C. (2002) Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res. 30, E48.
Srinivasan, M., Sedmak, D., and Jewell, S. (2002) Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am. J. Pathol. 161, 1961–1971.
Al-Mulla, F., Al-Tamimi, R., and Bitar, M. S. (2004) Comparison of two probe preparation methods using long oligonucleotide microarrays. Biotechniques 37, 827–833.
Goff, L. A., Bowers, J., Schwalm, J., Howerton, K., Getts, R. C., and Hart, R. P. (2004) Evaluation of sense-strand mRNA amplification by comparative quantitative PCR. BMC Genomics 5, 76.
Auer, H., Lyianarachchi, S., Newsom, D., Klisovic, M. I., Marcucci, G., and Kornacker, K. (2003) Chipping away at the chip bias: RNA degradation in microarray analysis. Nat. Genet. 35, 292–293.
Cole, K. A., Krizman, D. B., and Emmert-Buck, M. R. (1999) The genetics of cancer-a 3D model. Nat. Genet. 21, 38–41.
Ehrig, T., Abdulkadir, S. A., Dintzis, S. M., Milbrandt, J., and Watson, M. A. (2001) Quantitative amplification of genomic DNA from histological tissue sections after staining with nuclear dyes and laser capture microdissection. J. Mol. Diagn. 3, 22–25.
Lasken, R. S. and Egholm, M. (2003) Whole genome amplification: abundant supplies of DNA from precious samples or clinical specimens. Trends Biotechnol. 21, 531–535.
Wang, G., Brennan, C., Rook, M., et al. (2004) Balanced-PCR amplification allows unbiased identification of genomic copy changes in min cell and tissue samples. Nucleic Acids Res. 32, E76.
Makrigiorgos, G. M., Chakrabarti, S., Zhang, Y., Kaur, M., and Price, B. D. (2002) A PCR-based amplification method retaining the quantitative difference between two complex genomes. Nat. Biotechnol. 20, 936–939.
Stoecklein, N. H., Erbersdobler, A., Schmidt-Kittler, O., et al. (2002) SCOMP is superior to degenerated oligonucleotide primed-polymerase chain reaction for global amplification of min amounts of DNA from microdissected archival tissue samples. Am. J. Pathol. 161, 43–51.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Al-Mulla, F. (2007). Utilization of Microarray Platforms in Clinical Practice. In: Rampal, J.B. (eds) Microarrays. Methods in Molecular Biology, vol 382. Humana Press. https://doi.org/10.1007/978-1-59745-304-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-59745-304-2_8
Publisher Name: Humana Press
Print ISBN: 978-1-58829-944-4
Online ISBN: 978-1-59745-304-2
eBook Packages: Springer Protocols